Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06680869 · ClinicalTrials.gov registry record · Phase 3
Early Amiodarone in Shockable Cardiac Arrest
A Phase 3 study of Cardiac Arrest, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 585
- Enrollment target
- 1
- Study location
NCT06680869: Recruiting Phase 3 study of Cardiac Arrest, sponsored by Oregon Health and Science University.
NCT06680869 is a Phase 3 study of Cardiac Arrest that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 585 participants, below the 1,461-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06680869, a Phase 3 study of Cardiac Arrest, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 585 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same cycle as the initial dose of epinephrine) improves the time to amiodarone delivery in those with out-of-hospital cardiac arrest due to refractory ventricular fibrillation or ventricular tachycardia compared to usual care.
Conditions Studied
Interventions
- DRUG Amiodarone Hydrochloride Injection
- OTHER Usual Care Protocol
Study Locations (1)
Oregon
- Oregon Health & Sciences University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2028-01-31 |
| Phase | Phase 3 |
What NCT06680869 shows while recruiting
NCT06680869 is an interventional study that assigns participants to a tested intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap, below the 1,461-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 2 interventions - of which Amiodarone Hydrochloride Injection is the first listed.
NCT06680869 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06680869 about?
NCT06680869 is a clinical study titled "Early Amiodarone in Shockable Cardiac Arrest". The primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same cycle as the initial...
What is the current status of trial NCT06680869?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 585 participants. The study started on 2025-01-01. Estimated completion is 2028-01-31.
What conditions does trial NCT06680869 study?
This clinical trial studies the following conditions: Cardiac Arrest.
What interventions are being tested in trial NCT06680869?
The interventions under investigation include: Amiodarone Hydrochloride Injection (DRUG), Usual Care Protocol (OTHER).
Who is sponsoring clinical trial NCT06680869?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06680869 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06680869's enrollment target sits among peer trials
585 10th of 31 higher than 22 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
Quality of Pediatric Resuscitation in a Multicenter Collaborative
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02803957 · 585 participants · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
- NCT06183281 · 586 participants · NA
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI